AGNC Investment Corp. Other Income (Expense) decreased by 154.9% to -$433.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 434.6%, from -$81.00M to -$433.00M. Over 3 years (FY 2021 to FY 2025), Other Income (Expense) shows an upward trend with a 35.7% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$621.00M | -$45.00M | -$254.00M | -$1.08B | -$729.00M | -$824.00M | -$31.00M | $378.00M | -$316.00M | $466.00M | $497.00M | -$21.00M | $440.00M | $39.00M | -$81.00M | -$274.00M | $688.00M | $789.00M | -$433.00M |
| QoQ Change | — | +92.8% | -464.4% | -324.4% | +32.4% | -13.0% | +96.2% | >999% | -183.6% | +247.5% | +6.7% | -104.2% | >999% | -91.1% | -307.7% | -238.3% | +351.1% | +14.7% | -154.9% |
| YoY Change | — | — | — | — | -17.4% | <-999% | +97.1% | +151.9% | +61.7% | — | >999% | -105.6% | +239.2% | -91.6% | -116.3% | <-999% | +56.4% | >999% | -434.6% |